Custom Antibody Market Overview:
In a recent research report by Market Research Community, the Custom Antibody Market is expected to surpass USD 146.40 by the year 2030, from USD 40.97 Billion in 2021.
Custom antibody services involve modifying antibodies for use in development and research. In recent years, there has been a noticeable rise in the demand for the newest diagnostic medical methods. This expansion can be attributed to rising prevalence rates, a general audience that has approved tailored items with high-quality standards, rising healthcare spending, and increased awareness for public health issues among technology advancements.
Top Key Players of the Custom Antibody Market:
Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc, Merck Group, Cell Signaling Technology, Inc., GenScrip, BioLegend, Rockland Immunochemicals, Agilent Technologies, Inc., BioLegend, Inc., Innovagen AB.
Types Covered in This Report Are:
Other Custom Antibodies
On the Basis of Application:
Pharmaceutical Biotechnology Companies
Academic Research Institutes
Contract Research Organizations
By Research Area:
Other Research Areas
North America– (U.S., Canada, Mexico)
Europe- (Germany, France, U.K., Russia, Italy, Spain, BENELUX, Rest of Europe)
Asia Pacific- (China, Japan, India, South Korea, Australia, ASEAN, Rest of Asia Pacific)
Latin America- (Brazil, Argentina, Chile, Rest of Latin America)
Middle East and Africa- (GCC, Turkey, Israel, Rest of MEA)
The Mice segment of the custom antibody market holds the highest market share. The majority of research antibodies are produced in mice. Mice are small and simple to handle and carry as compared to other animals, and they also require less nutrition than other animals.
The regional segment of the custom antibody market is divided into North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. Due to growing investments in the research and development of pharmaceuticals used to treat a wide range of ailments, North America represents a significant portion of the global market for custom antibodies. The region's custom antibody market is expected to rise as a result of increased demand for protein therapeutic antibody pharmaceuticals and the adoption of personalized medicines.
The Custom Antibody market is projected to grow at a significant pace reaching a CAGR of approximately 27.2%, over the forecast period of 2022–2030, despite a considerable fall in Service sales during the initial phase of pandemic spread and lockdown restrictions imposed globally.
The study is consolidated into major segments and further into sub-segments, such as by Service (Antibody Development, Antibody Production Purification, Antibody Fragmentation Labeling), Type (Monoclonal Antibodies, Polyclonal Antibodies
Recombinant Antibodies, Other Custom Antibodies), Source (Mice, Rabbits, Other Sources), Research Area (Oncology, Infectious Diseases, Neurobiology, Stem Cells, Immunology, Cardiovascular Disease, Other Research Areas), End User (Pharmaceutical Biotechnology Companies, Academic Research Institutes, Contract Research Organizations) to forecast the Custom Antibody Market size by value; also includes the analysis of past market dynamics from 2016 – 2021, considering 2021 as the base year.
The research provides answers to the following key questions:
- What is the expected growth rate of the Custom Antibody Market? What will be the market size for the forecast period, 2022 - 2030?
- What are the major driving forces responsible for transforming the trajectory of the industry?
- Who are major vendors dominating the Custom Antibody industry across different regions? What are their winning strategies to stay ahead in the competition?
- What are the market trends business owners can rely upon in the coming years?
- What are the threats and challenges expected to restrict the progress of the industry across different countries?
- What are the key opportunities that business owners can bank on for the forecast period, 2022 - 2030?
Our Recently Published Reports
Market Research Community